Chaturvedi et al., 2022 - Google Patents
Skin-on-ChipChaturvedi et al., 2022
- Document ID
- 12485610913824815797
- Author
- Chaturvedi D
- Mukherjee S
- Sawant P
- Jain P
- Majumder A
- Publication year
- Publication venue
- Microfluidics and Multi Organs on Chip
External Links
Snippet
In the last few decades, skin bioengineering has undergone several advancements. The need, understanding, and importance of developing artificial skin, ie in vitro human skin models (HSMs) such as static and dynamic perfusion-based skin-on-chip (SOC) models for …
- 210000003491 Skin 0 abstract description 258
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mohammadi et al. | Skin diseases modeling using combined tissue engineering and microfluidic technologies | |
Risueño et al. | Skin-on-a-chip models: General overview and future perspectives | |
Randall et al. | Advances in the biofabrication of 3D skin in vitro: healthy and pathological models | |
JP7227211B2 (en) | Artificial three-dimensional skin tissue, its array, and its manufacturing method | |
Klicks et al. | In vitro skin three-dimensional models and their applications | |
Ramasamy et al. | Optimized construction of a full thickness human skin equivalent using 3D bioprinting and a PCL/collagen dermal scaffold | |
Fetah et al. | The emergence of 3D bioprinting in organ-on-chip systems | |
Radhakrishnan et al. | Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips | |
Sriram et al. | Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function | |
Lee et al. | Design and fabrication of human skin by three-dimensional bioprinting | |
Kimlin et al. | 3D in vitro tissue models and their potential for drug screening | |
Kaisar et al. | New experimental models of the blood-brain barrier for CNS drug discovery | |
Varone et al. | A novel organ-chip system emulates three-dimensional architecture of the human epithelia and the mechanical forces acting on it | |
Nitsche et al. | Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review | |
Zoio et al. | Skin-on-a-chip technology: microengineering physiologically relevant in vitro skin models | |
WO2018237132A1 (en) | Vascularized microfluidic platforms | |
CN113950339A (en) | 3D biological printing skin tissue model | |
US20200239857A1 (en) | Stretchable skin-on-a-chip | |
Bal-Öztürk et al. | Current strategies and future perspectives of skin-on-a-chip platforms: innovations, technical challenges and commercial outlook | |
Jones et al. | Design of an integrated microvascularized human skin-on-a-chip tissue equivalent model | |
Fernandes et al. | 3D Bioprinting: an enabling technology to understand melanoma | |
Mohamadali et al. | Design and evaluation of a skin-on-a-chip pumpless microfluidic device | |
Ejiugwo et al. | Toward developing immunocompetent diabetic foot ulcer-on-a-chip models for drug testing | |
Cui et al. | Recent Progress in Skin‐on‐a‐Chip Platforms | |
Quan et al. | Analysis of drug efficacy for inflammatory skin on an organ-chip system |